Mallinckrodt’s Dr. David Keenan is Named Chairman of BioPharmaChem Ireland

BioPharmaChem Ireland (BPCI), the Irish Business and Employers’ Confederation (IBEC) group that represents the sector, has named Dr. David Keenan, Vice President of Global External Supply and Managing Director of Mallinckrodt Pharmaceutical Ireland, as its new chairman.

Dr. Keenan will serve a two-year term replacing outgoing chair Seamus Fives, Site Leader at Pfizer Pharmaceuticals.

Commenting on the new appointment during BCPI’s annual general meeting in Dublin, Director of BPCI Matt Moran stated: “We work in an exciting, dynamic and innovative industry that is a key driver of the substance behind the Irish business model, and I look forward to continuing this momentum with our incoming Chair Dr. David Keenan, whom I know will strive to further the growth prospects for our sector in the years ahead.”

“The biopharmaceutical sector has been a major driver of business substance and export growth, with the latest figures at €55 billion accounting for 58% of Irish goods exports. With investment of more than €4 billion in the past couple of years, we’re now preparing for a rapid and substantial increase in job creation with as many as 8,400 jobs to be added by 2020.”

Accepting the award, Keenan said, “I’m honored and delighted to accept the position and will be following in the footsteps of other great leaders. Education and the opportunities this gives young people, no matter their background, is a particular passion of mine.” This will be one of his focus areas during his chairmanship.

Dr. Keenan received the prestigious JC Savage Business Person of the Year Excellence Award from the Fingal Dublin Chamber this past November. Selected among a pool of 250 candidates, he was recognized not only for his exemplary work at Mallinckrodt, but also for his efforts to advance the pharmaceutical industry’s growth in the region.

About BioPharmaChem
BioPharmaChem’s mission is to influence, support and represent the sector in realizing its ambition by bringing together all relevant stakeholders in the State, namely: industry, the government, the research community and the public at large to effectively communicate the unique attractiveness of Ireland as a leading location for the supply and development of pharmaceutical products. To learn more, visit